272 related articles for article (PubMed ID: 32935478)
1. IL-37: An anti-inflammatory cytokine with antitumor functions.
Mei Y; Liu H
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1151. PubMed ID: 32935478
[TBL] [Abstract][Full Text] [Related]
2. Current Understanding of IL-37 in Human Health and Disease.
Su Z; Tao X
Front Immunol; 2021; 12():696605. PubMed ID: 34248996
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process.
Gu M; Jin Y; Gao X; Xia W; Xu T; Pan S
Front Immunol; 2023; 14():1278521. PubMed ID: 37928545
[TBL] [Abstract][Full Text] [Related]
4. The indirect antiangiogenic effect of IL-37 in the tumor microenvironment.
Mei Y; Zhu Y; Teo HY; Liu Y; Song Y; Lim HY; Binte Hanafi Z; Angeli V; Liu H
J Leukoc Biol; 2020 May; 107(5):783-796. PubMed ID: 32125036
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
Voronov E; Apte RN
Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
[TBL] [Abstract][Full Text] [Related]
6. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
Apte RN; Voronov E
Immunol Rev; 2008 Apr; 222():222-41. PubMed ID: 18364005
[TBL] [Abstract][Full Text] [Related]
7. Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors.
Airoldi I; Ribatti D
J Leukoc Biol; 2011 Nov; 90(5):875-82. PubMed ID: 21750124
[TBL] [Abstract][Full Text] [Related]
8. [Interleukin-33: Friend or Enemy in the Fight against Tumors?].
Gorbacheva AM; Mitkin NA
Mol Biol (Mosk); 2019; 53(5):774-789. PubMed ID: 31661477
[TBL] [Abstract][Full Text] [Related]
9. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
10. Th17 Cell Plasticity and Functions in Cancer Immunity.
Guéry L; Hugues S
Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factors: a central link between inflammation and cancer.
Triner D; Shah YM
J Clin Invest; 2016 Oct; 126(10):3689-3698. PubMed ID: 27525434
[TBL] [Abstract][Full Text] [Related]
12. IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis.
Fahey E; Doyle SL
Front Immunol; 2019; 10():1426. PubMed ID: 31293586
[TBL] [Abstract][Full Text] [Related]
13. Neurotransmitters: emerging targets in cancer.
Jiang SH; Hu LP; Wang X; Li J; Zhang ZG
Oncogene; 2020 Jan; 39(3):503-515. PubMed ID: 31527667
[TBL] [Abstract][Full Text] [Related]
14. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases.
Bai J; Li Y; Li M; Tan S; Wu D
Curr Drug Targets; 2020; 21(9):855-863. PubMed ID: 32348214
[TBL] [Abstract][Full Text] [Related]
15. IL-36 Signaling in the Tumor Microenvironment.
Chelvanambi M; Weinstein AM; Storkus WJ
Adv Exp Med Biol; 2020; 1240():95-110. PubMed ID: 32060891
[TBL] [Abstract][Full Text] [Related]
16. Insight into interleukin-37: The potential therapeutic target in allergic diseases.
Huang Z; Xie L; Li H; Liu X; Bellanti JA; Zheng SG; Su W
Cytokine Growth Factor Rev; 2019 Oct; 49():32-41. PubMed ID: 31672283
[TBL] [Abstract][Full Text] [Related]
17. IL-1 Signaling in Tumor Microenvironment.
Zhang W; Borcherding N; Kolb R
Adv Exp Med Biol; 2020; 1240():1-23. PubMed ID: 32060884
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
20. Suppression of inflammation and acquired immunity by IL-37.
Cavalli G; Dinarello CA
Immunol Rev; 2018 Jan; 281(1):179-190. PubMed ID: 29247987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
